Tanvex BioPharma, Inc. (6541.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In TWD
| Market Cap | 13.46B |
| Enterprise Value | 14.16B |
| P/E Ratio | -6.68 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 20.42 |
| Price/Book Ratio | 1.84 |
| Enterprise/Revenue | 22.97 |
| Enterprise/EBITDA | -11.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.94 |
| Operating Margin | -2.89 |
| Return On Assets | -0.19 |
| Return On Equity | -0.26 |
| Revenue | 400.97M |
| Revenue/Share | 1.83 |
| Gross Profit | -440.71M |
| EBITDA | -1.02B |
| Net Income | -1.5B |
| Diluted EPS | -6.13 |
| Total Cash | 442.24M |
| Total Cash/Share | 1.67 |
| Total Debt | 1.68B |
| Total Debt/Equity | 0.31 |
| Current Ratio | 1.33 |
| Book Value Per Share | 20.29 |
| 52-Week Change | -27.15 |
| 52-Week High | 68 |
| 52-Week Low | 36.5 |
| Moving Average 50 Days | 40.06 |
| Moving Average 200 Days | 47.08 |
| Average Volume | 459,375 |
| Shares Outstanding | 264.99M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 333:1000 |
| Last Split Date | March 02, 2023 |